Suppr超能文献

α-甲基对酪氨酸(AMPT)对未服用药物的抑郁症患者的影响。

Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients.

作者信息

Miller H L, Delgado P L, Salomon R M, Heninger G R, Charney D S

机构信息

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

Neuropsychopharmacology. 1996 Mar;14(3):151-7. doi: 10.1016/0893-133X(95)00072-L.

Abstract

A variety of biologic studies have demonstrated abnormal regulation of the norepinephrine (NE) system in patients with major depression, suggesting a role for NE in the etiology of depression. Brain NE and dopamine levels can be rapidly reduced by blocking synthesis with the tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (AMPT). In the current investigation, AMPT was administered to drug-free depressed patients to evaluate the effect on mood of diminished catecholamine levels. Seventeen drug-free patients meeting DSM-III-R criteria for major depressive episode were tested with AMPT and an active placebo control, diphenhydramine. Testing was accomplished in a double-blind, crossover fashion, with random assignment to test conditions. Each test included baseline evaluation, 2 days with administration of either AMPT or diphenhydramine, and a follow-up day. Diphenhydramine was used as an active control because of the significant sedation associated with AMPT. Behavioral ratings, including visual analogue scales for a variety of feeling states, the Hamilton Depression Rating Scale (HDRS), and plasma for 3-methoxy-4-hydroxyphenelethyleneglycol (MPHG) and homovanillic acid (HVA) levels, were obtained. AMPT significantly reduced plasma HVA by 70% and MHPG by 50%, but it had no significant effects on the HDRS. AMPT also significantly increased visual analogue ratings of "tired" and decreased ratings of "energetic." Diphenhydramine significantly decreased HDRS scores, but the change was small and was not clinically apparent. The lack of AMPT effects on depressed mood, in conjunction with a prior report that large reductions in plasma tryptophan do not systematically alter depressed mood, indicate that monoamine deficiency by itself is insufficient explanation of the cause of depression. The role of the noradrenergic system needs to be considered in relationship to the many other neurobiologic factors that could be involved in the pathophysiology of depression.

摘要

各种生物学研究表明,重度抑郁症患者去甲肾上腺素(NE)系统调节异常,这表明NE在抑郁症病因中起一定作用。用酪氨酸羟化酶抑制剂α-甲基-对-酪氨酸(AMPT)阻断去甲肾上腺素合成,可使脑内NE和多巴胺水平迅速降低。在本研究中,对未服用药物的抑郁症患者给予AMPT,以评估儿茶酚胺水平降低对情绪的影响。17名符合DSM-III-R重度抑郁发作标准的未服用药物的患者接受了AMPT和活性安慰剂对照药物苯海拉明的测试。测试采用双盲、交叉方式进行,随机分配测试条件。每次测试包括基线评估、服用AMPT或苯海拉明2天以及随访1天。由于AMPT有明显的镇静作用,所以使用苯海拉明作为活性对照。获得了行为评分,包括各种感觉状态的视觉模拟量表、汉密尔顿抑郁量表(HDRS),以及血浆3-甲氧基-4-羟基苯乙二醇(MPHG)和高香草酸(HVA)水平。AMPT使血浆HVA显著降低70%,使MHPG显著降低50%,但对HDRS没有显著影响。AMPT还显著提高了“疲倦”的视觉模拟评分,降低了“精力充沛”的评分。苯海拉明显著降低了HDRS评分,但变化很小,临床上不明显。AMPT对抑郁情绪没有影响,再结合之前的一份报告,即血浆色氨酸大幅降低并不会系统性地改变抑郁情绪,这表明单胺缺乏本身不足以解释抑郁症的病因。去甲肾上腺素能系统的作用需要结合许多其他可能参与抑郁症病理生理过程的神经生物学因素来考虑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验